Naval Medical Logistics Command, Code 05, Building 833, Fort Detrick, Frederick, MD 21702-5015

65 -- MEDICAL EQUIPMENT AND SUPPLIES SOL N62645-95-R-0054. Contact Ralph Payne, Contract Specialist, 301/619-3018; Terry L. Horst, Contracting Officer, 301/619-3012. The Naval Medical Logistics Command has a requirement for seven Biohazardous Waste Destruction and Decontamination Systems. The system shall be capable of processing at least 40 urine specimen bottles (120 ml bottles) for decontamination and destruction. Total estimated processing time is 15 minutes for entire cycle from system setup to completion of cycle. Infectious waste shall be sterilized and rendered noninfectious before compacting or grinding. Bottles and labels will be destroyed along with labels. Treated liquid will be pumped to the sewer. In the event of a complete system failure or irreparable jam in the processing chamber during a treatment cycle, the entire stainless steel chamber must be removable and be able to be placed in a standard steam autoclave for decontamination prior to discharging the waste load and dislodging the jam or repairing or replacing the blades. The system must be designed with minimal or no risk of exposure to potentially hazardous or dangerous conditions to the operator. The following Steris Corporation items are required for each EcoCycle 10 System #P3100: EcoCycle Processor #P3000; Processing Chamber with Collection Cap #C3200; Processing Cap with HEPA Filter #C3210; Chamber Caddle #C3220; Cap Liner with Indicator #A3100; Steris-SW Biohazardous Waste Decontaminant #S3000; Steris-LW Biohazardous Waste Decontaminant #S3050; Waste Collection Bag #A3110. The contract is contemplated to be a Firm Fixed Price contract. The Navy intends to negotiate with Steris Corporation, 9450 Pineneedle Drive, Mentor, OH 44060 as the only source that can provide the aforementioned systems. This notice is not a request for competitive proposals. Responses shall contain sufficient documentation to establish a bonafide capability to fulfill the requirements. Any new treatment techniques shall be acceptable to local regulating authorities, shall have scientific evidence of efficacy, and successful use in healthcare facilities for a minimum of two years. See Note 22. All inquiries must be in writing and may be telefaxed to 301/619-2925. (145)

Loren Data Corp. http://www.ld.com (SYN# 0359 19950526\65-0001.SOL)